Artificial intelligence wants to change the future of medicine next. And now, it might be on the verge of actually happening.

‍What’s happening:‍

• Cambridge, Massachusetts based medical technology startup OpenEvidence has raised $75M USD in a Series A financing round
  
• The funding round was led by Sequoia Capital
  

By the numbers:‍

• OpenEvidence has now raised more than $100M USD in venture capital funding since inception
  
• Their artificial intelligence technology has been trained on more than 35M peer reviewed publications
  
• In a comparison with OpenAI’s ChatGPT, OpenEvidence’s model made 77% less errors when asked questions from medical exams
  

The big idea:‍

• OpenEvidence has developed one of the most advanced large language models for doctors to be able to use to make clinical decisions and rapidly find reputable medical evidence that are related to specific questions from patients
  

Why it matters:‍

• OpenEvidence has quickly emerged as one of the most important startups in America using artificial intelligence technology for medical purposes and has already struck multiple notable scientific partnerships, including with The New England Journal of Medicine
  

Going deeper:‍

• OpenEvidence has publicly stated that a quarter of all doctors and physicians in the United States of America are already using their technology

‍